Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8978857rdf:typepubmed:Citationlld:pubmed
pubmed-article:8978857lifeskim:mentionsumls-concept:C0038477lld:lifeskim
pubmed-article:8978857lifeskim:mentionsumls-concept:C0032172lld:lifeskim
pubmed-article:8978857lifeskim:mentionsumls-concept:C0243076lld:lifeskim
pubmed-article:8978857lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:8978857pubmed:issue26lld:pubmed
pubmed-article:8978857pubmed:dateCreated1997-1-24lld:pubmed
pubmed-article:8978857pubmed:abstractTextPhomactins, natural products isolated from the culture broth of marine fungus Phoma sp., were found to be active as PAF antagonists. This unique carbon skeleton led us to investigate the structure-activity relationship demonstrating that the lipophilicity at C-(7-8), acetoxy, (methoxycarbonyl)oxy, and 3-isoxazolyloxy substitution at C-20, and 2-beta-OH configuration at C-2 are all required for the enhancement of inhibitor activity.lld:pubmed
pubmed-article:8978857pubmed:languageenglld:pubmed
pubmed-article:8978857pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8978857pubmed:citationSubsetIMlld:pubmed
pubmed-article:8978857pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8978857pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8978857pubmed:statusMEDLINElld:pubmed
pubmed-article:8978857pubmed:monthDeclld:pubmed
pubmed-article:8978857pubmed:issn0022-2623lld:pubmed
pubmed-article:8978857pubmed:authorpubmed-author:MatsushitaYYlld:pubmed
pubmed-article:8978857pubmed:authorpubmed-author:SaitoKKlld:pubmed
pubmed-article:8978857pubmed:authorpubmed-author:SatoAAlld:pubmed
pubmed-article:8978857pubmed:authorpubmed-author:SuganoMMlld:pubmed
pubmed-article:8978857pubmed:authorpubmed-author:IijimaYYlld:pubmed
pubmed-article:8978857pubmed:authorpubmed-author:TakaishiSSlld:pubmed
pubmed-article:8978857pubmed:issnTypePrintlld:pubmed
pubmed-article:8978857pubmed:day20lld:pubmed
pubmed-article:8978857pubmed:volume39lld:pubmed
pubmed-article:8978857pubmed:ownerNLMlld:pubmed
pubmed-article:8978857pubmed:authorsCompleteYlld:pubmed
pubmed-article:8978857pubmed:pagination5281-4lld:pubmed
pubmed-article:8978857pubmed:dateRevised2000-12-18lld:pubmed
pubmed-article:8978857pubmed:meshHeadingpubmed-meshheading:8978857-...lld:pubmed
pubmed-article:8978857pubmed:meshHeadingpubmed-meshheading:8978857-...lld:pubmed
pubmed-article:8978857pubmed:meshHeadingpubmed-meshheading:8978857-...lld:pubmed
pubmed-article:8978857pubmed:meshHeadingpubmed-meshheading:8978857-...lld:pubmed
pubmed-article:8978857pubmed:meshHeadingpubmed-meshheading:8978857-...lld:pubmed
pubmed-article:8978857pubmed:year1996lld:pubmed
pubmed-article:8978857pubmed:articleTitleStructure-activity relationships of phomactin derivatives as platelet activating factor antagonists.lld:pubmed
pubmed-article:8978857pubmed:affiliationBiomedical Research Laboratories, Sankyo Co. Ltd, Tokyo, Japan.lld:pubmed
pubmed-article:8978857pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:8978857lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8978857lld:pubmed